AF
OPNT

Advisornet Financial’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Advisornet Financial’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50
Closed – – 1932
2020
Q2 		$0 Hold
50
– – ﹤0.01% 1976
2020
Q1 		$0 Hold
50
– – ﹤0.01% 1987
2019
Q4 		$1K Hold
50
– – ﹤0.01% 1810
2019
Q3 		$1K Buy
+50
New +$697 ﹤0.01% 1808

Other funds holding OPNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advisornet Financial's OPNT Position: Q3 2020 in Review

Advisornet Financial sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q3 2020, closing a stake of 50 shares.

Advisornet Financial first reported a position in OPNT in Q3 2019 and held it in 4 quarters. The position peaked at $1K in Q4 2019. 28 funds tracked by Wall St. Rank hold OPNT as of Q3 2020.

  • Advisornet Financial reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Advisornet Financial sold 50 Opiant Pharmaceuticals, Inc. Common Stock shares in Q3 2020.
  • Advisornet Financial first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • Advisornet Financial's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q4 2019.
  • 28 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on Advisornet Financial's 13F filing for Q3 2020, filed 6 Nov 2020.